ArticleInternal and emergency medicine2025
Intracerebral hemorrhage hospitalizations and outcomes: comparisons between institutional and national data.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Berberine targets the PI3Kα LYS672 site to suppress the PI3K/Akt/NF-κB axis and modulate microglial functional states after intracerebral hemorrhage.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026Article
- Incidence and risk factors for post-stroke delirium in the elderly: A national inpatient sample (NIS) analysis.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Intracerebral hemorrhage (ICH) accounts for 10-15% of all strokes in the United States (US), with in-hospital mortality rates reaching 40-50%. This study addresses a critical gap in understanding ICH outcomes in Alabama, where data has historically been absent from the National Inpatient Sample (NIS), despite the state's high burden of stroke incidence and mortality. To compare in-hospital mortality rates and length of stay (LOS) among patients with ICH treated at a comprehensive stroke center in Alabama versus large urban hospitals across the US, we conducted a retrospective analysis of data from 425 ICH patients treated at the academic comprehensive stroke center in Alabama (2016-2019) and 68,525 patients from the NIS (2016-2018). Patients were aged 18 and older with a diagnosis of ICH. We utilized multivariable logistic regression to assess mortality and linear regression for LOS, adjusting for demographics and procedures. The patients at the Alabama center were generally younger, white, and more likely to be females. The comprehensive stroke center reported an in-hospital mortality rate of 27.76 per 100 patients (95% CI = 22.76, 32.77), which was higher than the NIS average of 22.02 per 100 patients (95% CI = 21.69, 22.37). Additionally, patients at the Alabama center had 33.5% higher odds of in-hospital mortality compared to South Atlantic hospitals (OR = 1.34, 95% CI = 1.07-1.67, p = 0.0113). Lastly, the comprehensive stroke center demonstrated a significantly shorter LOS of 5.8 days (β = - 1.25; 95% CI = - 1.89, - 0.61; p = 0.0001) compared to the South Atlantic hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.